Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MH mutations on bi-directional DHPR-RyR1 coupling
Validating Molecular Signature Risk Models of NSCLC
Role of NIK in Osteoclastogenesis
Regulation of Acidification in the Omct
Nimh Clinical Training
Recently added grants:
Cognitive training to reduce incidence of cognitive impairment in older adults
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
An expandable polymeric valved conduit to repair congenital heart disease
Characterizing Human RPE Cell Proliferation to Advance Endogenous Regeneration
Multiplexed Detection of Mosquito-Borne Viruses at the Point-of-Care
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-008
Application #
7329467
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant